Jakarta—Indonesia’s national health insurance program, BPJS Kesehatan, is facing a significant fiscal challenge as the costs associated with treating cardiovascular diseases—specifically heart conditions and strokes—have surged to an alarming Rp 23 trillion. This figure, disclosed by the Indonesian Heart Association (PERKI) during a press conference commemorating World Heart Day 2026, highlights a growing crisis in the nation’s healthcare landscape, where expensive, late-stage medical interventions are consuming a disproportionate share of public health funding.
The financial strain caused by these "catastrophic diseases" is not merely a matter of administrative accounting but represents a broader public health failure in managing non-communicable diseases (NCDs) before they require complex, high-cost surgical procedures. As the government continues to grapple with the sustainability of the Universal Health Coverage (UHC) scheme, the medical community is now sounding the alarm, shifting the focus from expensive hospital-based treatments to early detection and risk management.
The Financial Anatomy of Cardiovascular Treatment
The staggering Rp 23 trillion expenditure is primarily driven by the high cost of advanced medical technology and surgical procedures. Dr. Ade Meidian Ambari, SpJP(K), PhD, Chairman of PERKI, provided a breakdown of why these conditions are so fiscally demanding. For instance, the implantation of a coronary stent, or "ring," costs between Rp 40 million and Rp 60 million per patient. More complex procedures, such as coronary artery bypass grafting, can reach Rp 150 million, while valve replacement surgeries can cost upwards of Rp 200 million.
While the presence of BPJS Kesehatan has been a lifeline for millions of Indonesians, allowing patients to access life-saving treatments that would otherwise be financially ruinous, the sheer volume of these cases is creating a systemic bottleneck. The transition from managing acute emergencies to funding chronic maintenance and major surgeries is stretching the insurance pool to its limit, necessitating a fundamental change in how the nation approaches heart health.
A Chronology of the Cardiovascular Crisis
The rise of cardiovascular diseases as a leading cause of death and financial expenditure in Indonesia did not happen overnight. Over the past two decades, the country has undergone a significant epidemiological transition. As infectious diseases were brought under better control, lifestyle-related conditions—often referred to as diseases of affluence—began to take center stage.
In the early 2010s, as the government prepared for the launch of the JKN (Jaminan Kesehatan Nasional) program in 2014, health experts warned that the shift toward sedentary lifestyles, smoking, and high-sodium diets would lead to a "tsunami" of chronic diseases. By 2018, data from the Basic Health Research (Riskesdas) already indicated that the prevalence of heart disease and stroke was rising among younger demographics.
The COVID-19 pandemic further exacerbated the situation. During the 2020–2022 period, many patients deferred routine check-ups and maintenance treatments for hypertension and diabetes, leading to a surge in acute cardiac events and strokes in the post-pandemic years. The 2026 World Heart Day conference serves as a pivotal moment, marking a realization that the current trajectory is unsustainable without aggressive preventative interventions.
Supporting Data and Demographic Trends
The data provided by PERKI reflects a broader global trend, yet Indonesia faces unique challenges due to its population size and varied levels of access to specialized cardiac care. Cardiovascular disease is currently the leading cause of death globally, but in Indonesia, it consistently ranks as the primary cause of death and the most expensive category for the national health insurance system.
According to recent health reports, the prevalence of hypertension—a key precursor to both heart disease and stroke—remains high among the adult population, with many cases remaining undiagnosed or untreated. The demographic shift is also a concern; while heart disease was historically considered a condition of the elderly, clinical data now suggests an increasing incidence of coronary heart disease in individuals under the age of 50. This shift is attributed to earlier onset of metabolic syndrome, obesity, and stress-related factors.
Official Responses and Recommendations
In response to the fiscal data, PERKI is advocating for a "shift to the upstream" approach. This policy recommendation involves moving resources away from the exclusive focus on tertiary hospital care and toward primary care facilities—the community health centers (Puskesmas)—where risk factors can be identified before they manifest as critical events.
Dr. Ade emphasized that the onus of health cannot rest solely on the healthcare system. "If we look at the financial impact, the most effective investment is not in the operating theater, but in the check-up clinic," he noted. PERKI’s guidelines for medical check-ups have been updated to reflect the need for earlier intervention:
- For the General Population: Individuals aged 40 and above should undergo an annual medical check-up.
- For High-Risk Individuals: Those with a family history of premature heart disease (defined as a father or brother diagnosed before age 55, or a mother or sister before age 65) should begin professional screenings at age 20.
- Maintenance: If initial screenings at age 40 are normal, subsequent screenings can be spaced out to every five years, provided no new symptoms or risk factors emerge.
Public health officials are also echoing the call for increased health literacy. Simple, self-administered checks—such as monitoring blood pressure at home, tracking blood sugar levels, and regular cholesterol screenings—are being promoted as essential habits. The integration of digital health tools, such as mobile apps to track heart rate and activity, is also being explored as a method to reduce the burden on formal medical facilities.
Broader Impact and Economic Implications
The economic implications of this health crisis extend beyond the BPJS Kesehatan balance sheet. When a primary breadwinner suffers a stroke or heart attack, the socioeconomic impact on the family is profound. The loss of productivity, the cost of long-term rehabilitation, and the burden on caregivers often lead to a cycle of poverty.
From a macroeconomic perspective, the rising cost of NCDs threatens to drain resources that could otherwise be allocated to other public health priorities, such as maternal and child health or infectious disease prevention. If the Rp 23 trillion expenditure continues to grow at its current rate, the government may eventually be forced to reconsider premium structures, coverage limits, or the co-payment model, all of which could impact the equity of the healthcare system.
Furthermore, the demand for cardiac specialists and advanced surgical equipment is placing pressure on the medical education system. Indonesia currently faces a shortage of cardiovascular specialists relative to its population. Training more specialists is a long-term goal, but in the short term, the health ministry is looking at ways to improve the diagnostic capabilities of general practitioners at the primary care level to ensure that high-risk patients are referred to specialized care before a crisis occurs.
A Call to Preventive Action
The message from the 2026 World Heart Day conference is clear: the current model of reacting to cardiac emergencies is not only medically inefficient but financially unsustainable. The medical community is calling for a "prevention-first" culture that involves government policy, private sector involvement, and individual responsibility.
For the average citizen, the path forward is to view healthcare not as a service to be used when sick, but as a discipline to be maintained while healthy. As Indonesia continues to develop its healthcare infrastructure, the lessons learned from the rising costs of heart disease will likely serve as a blueprint for managing other chronic, non-communicable conditions. Whether the government can effectively implement these preventative strategies will determine not just the financial stability of the national insurance system, but the longevity and quality of life for millions of Indonesians in the years to come.
As the nation moves forward, the synergy between technology, policy, and personal health management will be the defining factor in curbing the tide of cardiovascular disease. The Rp 23 trillion figure serves as a stark reminder of the cost of inaction, underscoring the urgent need for a shift in focus that prioritizes the health of the heart long before the warning signs become catastrophic.
